The multiple roles of Id-1 in cancer progression - PubMed
Review
The multiple roles of Id-1 in cancer progression
Ming-Tat Ling et al. Differentiation. 2006 Dec.
Abstract
Id-1 (Inhibitor of differentiation/DNA binding) is a member of the helix-loop-helix protein family expressed in actively proliferating cells. It regulates gene transcription by heterodimerization with the basic helix-loop-helix transcription factors and therefore inhibits them from DNA binding and transactivation of their target genes. Early studies showed that Id-1 functions mainly as a regulator in cellular differentiation of the muscle cells. The oncogenic role of Id-1 was revealed recently by the finding that Id-1 expression was able to induce cancer cell growth and promote cell survival. In addition, Id-1 protein was frequently overexpressed in over 20 types of cancer, supporting its role in the tumorigenesis of a wide range of tissues. However, the fact that Id-1 was able to activate multiple pathways involved in tumor progression suggests that Id-1 may in addition function in promotion of tumor development. For example, overexpression of Id-1 was found to induce expression of MT1-MMP protein, leading to invasion of breast cancer cells. A close association between Id-1 expression and angiogenesis has also been demonstrated recently in both normal and cancer cells. Accordingly, in prostate cancer cells, expression of Id-1 was able to activate EGF-R and nuclear factor-kappaB activities and resulted in progression to androgen independence. In addition, in both nasopharyngeal carcinoma and prostate cancer cells, Id-1 expression was found to protect the cells from chemotherapeutic drug-induced apoptosis through regulation of the Raf-1/MAPK and JNK pathways. This review will discuss recent evidence supporting the role of Id-1 in tumor progression and the mechanisms involved.
Similar articles
-
Ling MT, Wang X, Lee DT, Tam PC, Tsao SW, Wong YC. Ling MT, et al. Carcinogenesis. 2004 Apr;25(4):517-25. doi: 10.1093/carcin/bgh047. Epub 2003 Dec 19. Carcinogenesis. 2004. PMID: 14688027
-
Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.
Kim H, Chung H, Kim HJ, Lee JY, Oh MY, Kim Y, Kong G. Kim H, et al. Breast Cancer Res Treat. 2008 Nov;112(2):287-96. doi: 10.1007/s10549-007-9871-6. Epub 2007 Dec 25. Breast Cancer Res Treat. 2008. PMID: 18158619
-
Cheung HW, Ling MT, Tsao SW, Wong YC, Wang X. Cheung HW, et al. Carcinogenesis. 2004 Jun;25(6):881-7. doi: 10.1093/carcin/bgh087. Epub 2004 Jan 23. Carcinogenesis. 2004. PMID: 14742319
-
Role of Id family proteins in growth control.
Yokota Y, Mori S. Yokota Y, et al. J Cell Physiol. 2002 Jan;190(1):21-8. doi: 10.1002/jcp.10042. J Cell Physiol. 2002. PMID: 11807807 Review.
-
Iavarone A, Lasorella A. Iavarone A, et al. Cancer Lett. 2004 Feb 20;204(2):189-96. doi: 10.1016/S0304-3835(03)00455-5. Cancer Lett. 2004. PMID: 15013218 Review.
Cited by
-
Overexpression of Id3 induces apoptosis of A549 human lung adenocarcinoma cells.
Li XJ, Zhu CD, Yu W, Wang P, Chen FF, Xia XY, Luo B. Li XJ, et al. Cell Prolif. 2012 Feb;45(1):1-8. doi: 10.1111/j.1365-2184.2011.00792.x. Epub 2011 Dec 7. Cell Prolif. 2012. PMID: 22151756 Free PMC article.
-
Expression of Id-1 and VEGF in non-small cell lung cancer.
Kim MS, Park TI, Lee YM, Jo YM, Kim S. Kim MS, et al. Int J Clin Exp Pathol. 2013 Sep 15;6(10):2102-11. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24133588 Free PMC article.
-
Research Progress on the Mechanism of the Antitumor Effects of Cannabidiol.
Ma L, Liu M, Liu C, Zhang H, Yang S, An J, Qu G, Song S, Cao Q. Ma L, et al. Molecules. 2024 Apr 24;29(9):1943. doi: 10.3390/molecules29091943. Molecules. 2024. PMID: 38731434 Free PMC article. Review.
-
Fernandes Q, Allouch S, Gupta I, Elmakaty I, Elzawawi KE, Amarah A, Al-Thawadi H, Al-Farsi H, Vranic S, Al Moustafa AE. Fernandes Q, et al. Pathogens. 2022 Nov 19;11(11):1380. doi: 10.3390/pathogens11111380. Pathogens. 2022. PMID: 36422631 Free PMC article. Review.
-
The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer.
Diaz R, Nguewa PA, Diaz-Gonzalez JA, Hamel E, Gonzalez-Moreno O, Catena R, Serrano D, Redrado M, Sherris D, Calvo A. Diaz R, et al. Br J Cancer. 2009 Mar 24;100(6):932-40. doi: 10.1038/sj.bjc.6604938. Epub 2009 Feb 24. Br J Cancer. 2009. PMID: 19240717 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous